Positron Corporation (POSC)
USD 1.57
(-16.49%)
USD 1.57
(-16.49%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -353.46 Thousand USD | -332.24% |
| 2022 | -81.77 Thousand USD | -161.56% |
| 2021 | 132.84 Thousand USD | -17.37% |
| 2020 | 160.78 Thousand USD | -13.29% |
| 2019 | 185.41 Thousand USD | 190.41% |
| 2018 | 63.84 Thousand USD | 0.0% |
| 2014 | 104 Thousand USD | -75.47% |
| 2013 | 424 Thousand USD | -48.85% |
| 2012 | 829 Thousand USD | 199.28% |
| 2011 | 277 Thousand USD | 369.49% |
| 2010 | 59 Thousand USD | -53.54% |
| 2009 | 127 Thousand USD | 115.62% |
| 2008 | -813 Thousand USD | -313.39% |
| 2007 | 381 Thousand USD | -51.77% |
| 2006 | 790 Thousand USD | 250.19% |
| 2005 | -526 Thousand USD | -152.76% |
| 2004 | 997 Thousand USD | -4.32% |
| 2003 | 1.04 Million USD | 35.68% |
| 2002 | 768 Thousand USD | 309.84% |
| 2001 | -366 Thousand USD | -121.01% |
| 2000 | 1.74 Million USD | 625.83% |
| 1999 | 240 Thousand USD | -83.87% |
| 1998 | 1.48 Million USD | -26.59% |
| 1997 | 2.02 Million USD | 37.24% |
| 1996 | 1.47 Million USD | -26.15% |
| 1995 | 2 Million USD | -31.03% |
| 1994 | 2.9 Million USD | 45.0% |
| 1993 | 2 Million USD | -54.55% |
| 1992 | 4.4 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | -88.1 Thousand USD | 2.14% |
| 2023 Q4 | -90.02 Thousand USD | 19.89% |
| 2023 Q1 | -124.13 Thousand USD | -21413.86% |
| 2023 Q3 | -112.38 Thousand USD | -39.41% |
| 2023 FY | -353.46 Thousand USD | -332.24% |
| 2023 Q2 | -80.61 Thousand USD | 35.06% |
| 2022 Q3 | -150.44 Thousand USD | -118.52% |
| 2022 Q1 | -58.52 Thousand USD | -145.37% |
| 2022 FY | -81.77 Thousand USD | -161.56% |
| 2022 Q2 | -68.84 Thousand USD | -17.64% |
| 2022 Q4 | -577.00 USD | 99.62% |
| 2021 Q4 | 128.97 Thousand USD | 496.26% |
| 2021 Q3 | 21.63 Thousand USD | 145.24% |
| 2021 Q2 | -47.81 Thousand USD | -259.1% |
| 2021 Q1 | 30.05 Thousand USD | 0.0% |
| 2021 FY | 132.84 Thousand USD | -17.37% |
| 2020 FY | 160.78 Thousand USD | -13.29% |
| 2020 Q2 | 26.04 Thousand USD | 0.0% |
| 2019 FY | 185.41 Thousand USD | 190.41% |
| 2018 FY | 63.84 Thousand USD | 0.0% |
| 2015 Q1 | 136 Thousand USD | 403.7% |
| 2015 Q3 | 107 Thousand USD | -22.46% |
| 2015 Q2 | 138 Thousand USD | 1.47% |
| 2014 Q2 | 45 Thousand USD | 60.71% |
| 2014 FY | 104 Thousand USD | -75.47% |
| 2014 Q4 | 27 Thousand USD | 575.0% |
| 2014 Q3 | 4000.00 USD | -91.11% |
| 2014 Q1 | 28 Thousand USD | -82.93% |
| 2013 Q1 | 125 Thousand USD | 278.79% |
| 2013 Q2 | 14 Thousand USD | -88.8% |
| 2013 FY | 424 Thousand USD | -48.85% |
| 2013 Q3 | 121 Thousand USD | 764.29% |
| 2013 Q4 | 164 Thousand USD | 35.54% |
| 2012 Q3 | 106 Thousand USD | -67.98% |
| 2012 FY | 829 Thousand USD | 199.28% |
| 2012 Q2 | 331 Thousand USD | -7.8% |
| 2012 Q4 | 33 Thousand USD | -68.87% |
| 2012 Q1 | 359 Thousand USD | 660.94% |
| 2011 Q3 | -19 Thousand USD | 72.06% |
| 2011 FY | 277 Thousand USD | 369.49% |
| 2011 Q4 | -64 Thousand USD | -236.84% |
| 2011 Q2 | -68 Thousand USD | -115.89% |
| 2011 Q1 | 428 Thousand USD | 300.0% |
| 2010 Q1 | 284 Thousand USD | 1993.33% |
| 2010 FY | 59 Thousand USD | -53.54% |
| 2010 Q3 | -113 Thousand USD | -853.33% |
| 2010 Q4 | -214 Thousand USD | -89.38% |
| 2010 Q2 | 15 Thousand USD | -94.72% |
| 2009 FY | 127 Thousand USD | 115.62% |
| 2009 Q3 | -121 Thousand USD | -189.63% |
| 2009 Q2 | 135 Thousand USD | 5.47% |
| 2009 Q1 | 128 Thousand USD | 114.1% |
| 2009 Q4 | -15 Thousand USD | 87.6% |
| 2008 Q2 | 221 Thousand USD | 281.15% |
| 2008 Q3 | -4000.00 USD | -101.81% |
| 2008 Q4 | -908 Thousand USD | -22600.0% |
| 2008 Q1 | -122 Thousand USD | 66.58% |
| 2008 FY | -813 Thousand USD | -313.39% |
| 2007 FY | 381 Thousand USD | -51.77% |
| 2007 Q4 | -365 Thousand USD | -401.65% |
| 2007 Q1 | 379 Thousand USD | -22.81% |
| 2007 Q2 | 246 Thousand USD | -35.09% |
| 2007 Q3 | 121 Thousand USD | -50.81% |
| 2006 Q2 | 86 Thousand USD | 72.0% |
| 2006 FY | 790 Thousand USD | 250.19% |
| 2006 Q1 | 50 Thousand USD | 107.76% |
| 2006 Q3 | 163 Thousand USD | 89.53% |
| 2006 Q4 | 491 Thousand USD | 201.23% |
| 2005 FY | -526 Thousand USD | -152.76% |
| 2005 Q4 | -644 Thousand USD | -1563.64% |
| 2005 Q2 | 35 Thousand USD | -10.26% |
| 2005 Q3 | 44 Thousand USD | 25.71% |
| 2005 Q1 | 39 Thousand USD | -87.13% |
| 2004 Q1 | 125 Thousand USD | 54.32% |
| 2004 Q3 | 450 Thousand USD | 278.15% |
| 2004 Q4 | 303 Thousand USD | -32.67% |
| 2004 FY | 997 Thousand USD | -4.32% |
| 2004 Q2 | 119 Thousand USD | -4.8% |
| 2003 Q2 | 173 Thousand USD | -76.62% |
| 2003 Q4 | 81 Thousand USD | 68.75% |
| 2003 FY | 1.04 Million USD | 35.68% |
| 2003 Q3 | 48 Thousand USD | -72.25% |
| 2003 Q1 | 740 Thousand USD | 351.22% |
| 2002 Q4 | 164 Thousand USD | -16.75% |
| 2002 Q1 | 258 Thousand USD | 125.75% |
| 2002 Q2 | 149 Thousand USD | -42.25% |
| 2002 Q3 | 197 Thousand USD | 32.21% |
| 2002 FY | 768 Thousand USD | 309.84% |
| 2001 Q1 | 257 Thousand USD | 87.59% |
| 2001 Q4 | -1 Million USD | -579.43% |
| 2001 Q2 | 170 Thousand USD | -33.85% |
| 2001 FY | -366 Thousand USD | -121.01% |
| 2001 Q3 | 209 Thousand USD | 22.94% |
| 2000 Q3 | 459 Thousand USD | -3.37% |
| 2000 FY | 1.74 Million USD | 625.83% |
| 2000 Q2 | 475 Thousand USD | -29.21% |
| 2000 Q1 | 671 Thousand USD | 0.0% |
| 2000 Q4 | 137 Thousand USD | -70.15% |
| 1999 FY | 240 Thousand USD | -83.87% |
| 1998 FY | 1.48 Million USD | -26.59% |
| 1997 Q1 | 600 Thousand USD | 172.9% |
| 1997 FY | 2.02 Million USD | 37.24% |
| 1996 Q3 | 1.1 Million USD | 266.67% |
| 1996 Q4 | -823 Thousand USD | -174.82% |
| 1996 FY | 1.47 Million USD | -26.15% |
| 1996 Q2 | 300 Thousand USD | 250.0% |
| 1996 Q1 | -200 Thousand USD | -150.0% |
| 1995 Q2 | 1.2 Million USD | 1100.0% |
| 1995 Q1 | 100 Thousand USD | -93.33% |
| 1995 Q4 | 400 Thousand USD | 100.0% |
| 1995 Q3 | 200 Thousand USD | -83.33% |
| 1995 FY | 2 Million USD | -31.03% |
| 1994 Q2 | 300 Thousand USD | -50.0% |
| 1994 Q1 | 600 Thousand USD | 119.35% |
| 1994 FY | 2.9 Million USD | 45.0% |
| 1994 Q3 | 400 Thousand USD | 33.33% |
| 1994 Q4 | 1.5 Million USD | 275.0% |
| 1993 Q3 | 1.9 Million USD | 5.56% |
| 1993 Q2 | 1.8 Million USD | 0.0% |
| 1993 FY | 2 Million USD | -54.55% |
| 1993 Q4 | -3.1 Million USD | -263.16% |
| 1993 Q1 | 1.8 Million USD | 5.88% |
| 1992 Q3 | 1.7 Million USD | 6.25% |
| 1992 Q4 | 1.7 Million USD | 0.0% |
| 1992 FY | 4.4 Million USD | 0.0% |
| 1992 Q1 | 1.6 Million USD | 0.0% |
| 1992 Q2 | 1.6 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| CVR Medical Corp. | - USD | Infinity% |
| BioElectronics Corporation | 466.38 Thousand USD | 175.788% |
| IR-Med Inc. | -17 Thousand USD | -1979.206% |
| Polarean Imaging plc | 335.48 Thousand USD | 205.36% |
| Medical Supply International USA, Inc. | 1.75 Million USD | 120.098% |
| Avitar, Inc. | 836.7 Thousand USD | 142.245% |
| AVITA Medical, Inc. | 41.68 Million USD | 100.848% |
| Manhattan Scientifics, Inc. | -1000.00 USD | -35246.5% |
| Össur hf. | 485.57 Million USD | 100.073% |
| Zecotek Photonics Inc. | -195.32 Thousand USD | -80.966% |
| QHSLab, Inc. | 793.6 Thousand USD | 144.539% |
| Wellstar International, Inc. | - USD | Infinity% |
| Össur hf. | 485.57 Million USD | 100.073% |
| Bionovate Technologies Corp | - USD | Infinity% |
| EKF Diagnostics Holdings plc | 16.74 Million USD | 102.111% |
| Escalon Medical Corp. | 5.14 Million USD | 106.868% |
| Aurora Spine Corporation | 8.21 Million USD | 104.305% |
| BrainsWay Ltd. | 23.09 Million USD | 101.531% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| NewCardio, Inc. | 105.1 Thousand USD | 436.303% |
| Hamilton Thorne Ltd. | 35.08 Million USD | 101.007% |
| Vivos Inc. | -6036.00 USD | -5755.948% |
| MicroPort Scientific Corporation | 532.09 Million USD | 100.066% |
| Kelyniam Global, Inc. | 2.03 Million USD | 117.36% |
| REMSleep Holdings, Inc. | -756.73 Thousand USD | 53.291% |
| CYduct Diagnostics, Inc. | 56.59 Thousand USD | 724.563% |
| Nanomix Corporation | -69.45 Thousand USD | -408.89% |
| Theraclion SA | -1.08 Million USD | 67.283% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| Wellness Center USA, Inc. | 587.55 Thousand USD | 160.159% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Electromedical Technologies, Inc. | 1.04 Million USD | 133.808% |
| Lombard Medical, Inc. | 955 Thousand USD | 137.012% |
| ALR Technologies Inc. | 4945.00 USD | 7247.927% |
| Stratec SE | 71.58 Million USD | 100.494% |
| Vycor Medical, Inc. | 1.31 Million USD | 126.866% |
| Heart Tronics, Inc. | - USD | Infinity% |
| Nu-Med Plus, Inc. | -12.9 Thousand USD | -2640.039% |
| Perimeter Medical Imaging AI, Inc. | 206.41 Thousand USD | 271.237% |
| SANUWAVE Health, Inc. | 14.36 Million USD | 102.461% |
| VMS Rehab Systems, Inc. | -10.44 USD | -3385580.077% |
| Guided Therapeutics, Inc. | 36 Thousand USD | 1081.847% |
| Ingen Technologies, Inc. | 268.57 Thousand USD | 231.606% |
| Odyssey Group International, Inc. | - USD | Infinity% |
| United American Healthcare Corporation | -8000.00 USD | -4318.313% |
| ECGI Holdings, Inc. | - USD | Infinity% |
| Capital Group Holdings, Inc. | - USD | Infinity% |
| ADM Tronics Unlimited, Inc. | 1.09 Million USD | 132.308% |
| Urologix, Inc. | 6.09 Million USD | 105.801% |
| Rapid Therapeutic Science Laboratories, Inc. | - USD | Infinity% |
| Nexeon MedSystems Inc. | -316.69 Thousand USD | -11.612% |
| SS Innovations International, Inc. | 713.44 Thousand USD | 149.543% |
| Qualis Innovations, Inc. | - USD | Infinity% |
| Smith & Nephew plc | 3.91 Billion USD | 100.009% |
| NIOX Group Plc | 28.13 Million USD | 101.256% |
| Fuse Medical, Inc. | 10.73 Million USD | 103.293% |
| Broncus Holding Corporation | 7.22 Million USD | 104.891% |
| Brain Scientific Inc. | 54.32 Thousand USD | 750.649% |
| Pressure BioSciences, Inc. | 799.56 Thousand USD | 144.207% |
| Health Logic Interactive Inc. | - USD | Infinity% |